` CRON (Cronos Group Inc) vs S&P TSX Composite Index (Canada) Comparison - Alpha Spread

CRON
vs
S&P TSX Composite Index (Canada)

Over the past 12 months, CRON has underperformed S&P TSX Composite Index (Canada), delivering a return of -22% compared to the S&P TSX Composite Index (Canada)'s 16% growth.

Stocks Performance
CRON vs S&P TSX Composite Index (Canada)

Loading
CRON
S&P TSX Composite Index (Canada)
Add Stock

Performance Gap
CRON vs S&P TSX Composite Index (Canada)

Loading
CRON
S&P TSX Composite Index (Canada)
Difference

Performance By Year
CRON vs S&P TSX Composite Index (Canada)

Loading
CRON
S&P TSX Composite Index (Canada)
Add Stock

Competitors Performance
Cronos Group Inc vs Peers

S&P TSX Composite Index (Canada)
CRON
LLY
JNJ
NOVO B
ROG
Add Stock

Cronos Group Inc
Glance View

Market Cap
1.1B CAD
Industry
Pharmaceuticals

Cronos Group, Inc. engages in the production and distribution of cannabis. The company is headquartered in Toronto, Ontario. The company went IPO on 2014-05-07. The firm is focused on cannabis research, technology and product development. The Company’s portfolio includes PEACE NATURALS, COVE, Spinach, Lord Jones, Happy Dance and PEACE+. PEACE NATURALS a global wellness platform. The COVE and Spinach are adult-use brands. The Lord Jones, Happy Dance and PEACE+ are hemp-derived cannabidiol (CBD) brands. The Company’s segments include United States and Rest of World. The United States operating segment consists of the manufacture and distribution of hemp-derived CBD infused products. The Rest of World operating segment is involved in the cultivation, manufacture, and marketing of cannabis and cannabis-derived products for the medical and adult-use markets. The Company’s subsidiaries include Cronos Israel G.S. Cultivation Ltd, Cronos Israel G.S. Manufacturing Ltd., Cronos Israel G.S. Store Ltd. and Cronos Israel G.S. Pharmacy Ltd.

CRON Intrinsic Value
1.7 CAD
Overvaluation 43%
Intrinsic Value
Price
Back to Top